BioCentury
ARTICLE | Clinical News

Betafectin: Began a Phase III trial in 1200 patients to assess safety and efficacy at two doses. The primary end point is reduced percentages of serious infecti

February 27, 1995 8:00 AM UTC

Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin, PGG-glucan complex carbohydrate Indication: Prevent infection in gastrointestinal surgery Status: Began a Phase III trial in 12...